Hypertrophic cardiomyopathy is a rare condition that affects up to 1,000 children in the UK
Category: News
Early-stage endometriosis now visible through non-invasive imaging
Phase 2 trial reveals significant improvement in MASH patients
Inebilizumab shows sound efficacy in landmark research
Innovative antibody discovery could lead to new Parkinson’s treatments
Phase 3 research suggests a significant leap forward in myeloma management
Extended phase 2 study highlights macrophage cell therapy’s efficacy
Collaboration yields promising Barriolide therapy Enterothelin
Positive clinical data from phase 1 study presented at ASCO annual meeting